Dabigatran Impurity 28 | CAS 1381853-11-7 - Request Quote
Dabigatran Impurity 28
| SZ CAT No: | SZ-D012088 |
| CAS No | 1381853-11-7 |
| Mol.F. | C11H12ClN3O4 |
| Mol.Wt. | 285.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 28 is chemically 4-(2-Chloro-N-methylacetamido)-N-methyl-3-nitrobenzamide. Dabigatran Impurity 28 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 28 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1381853-11-7
Purchase 1381853-11-7
Order 1381853-11-7
Enquire 1381853-11-7
price of 1381853-11-7
1381853-11-7 Supplier
1381853-11-7 Manufacturer
1381853-11-7 Exporter
buy high quality Dabigatran Impurity 28
Purchase Dabigatran Impurity 28
Dabigatran Impurity 28 suppliers
Dabigatran Impurity 28 manufacturers
Dabigatran Impurity 28 price
Order Dabigatran Impurity 28
Enquire Dabigatran Impurity 28
Dabigatran Impurity 28 cost
Dabigatran Impurity 28 Supplier
Dabigatran Impurity 28 Distributor
Dabigatran Impurity 28 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 28 for ANDA Filing
Dabigatran Impurity 28 for Forced Degradation Studies
Dabigatran Impurity 28 Identification Standards
Dabigatran Impurity 28 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.